Kura Oncology, Inc.
KURA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001422143
In the last 90 days, Kura Oncology, Inc. insiders filed 2 open-market purchases and 8 sales; 221 institutions reported holding it in 13F filings for Q2 2026, worth $953.1M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Kura Oncology, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 171 | 152 | −19 |
| Shares | 67.6M | 66.7M | −881.2K (−1.3%) |
| Value | $1.41B | $1.25B | −$159.9M (−11.3%) |
New holders (10)
Institutions that held Kura Oncology, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Baker Bros. Advisors LP | 304,158 | $5.70M | 0.03% |
| Asymmetry Capital Management, L.P. | 194,309 | $3.64M | 2.19% |
| Gyon Technologies Capital Management, LP | 87,805 | $1.65M | 0.44% |
| Laurion Capital Management LP | 50,000 | $937.0K | 0.01% |
| HRT Financial LP | 42,467 | $795.0K | 0.00% |
| LMR Partners LLP | 38,460 | $720.0K | 0.01% |
| Bailard, Inc. | 10,434 | $195.0K | 0.01% |
| Key Financial Inc | 720 | $13.0K | 0.01% |
| TCI Wealth Advisors, Inc. | 160 | $3.00K | 0.00% |
| Bell Investment Advisors, Inc | 20 | $0 | 0.00% |
Sold out (29)
Institutions that held Kura Oncology, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.